Focalin IP Deal Between Celgene, Actavis Wins OK
A federal judge signed off Thursday on the dismissal of claims between plaintiffs Celgene Corp. and Novartis Pharmaceuticals Corp. and defendant Actavis South Atlantic LLC in a patent infringement suit over...To view the full article, register now.
Already a subscriber? Click here to view full article